Provista Diagnostics Nabs $3.9 Million in Hopes of Eliminating Unnecessary Biopsies

Without a biopsy, it’s difficult to determine whether a woman has breast cancer. But biopsies are costly and invasive – and often, in women with fibrous breast tissue and no cancer – they’re actually unnecessary.

Scottsdale startup Provista Diagnostics is developing a way to help diagnose women’s cancers more accurately – with just the use of a proteomics-based assay and standard imaging.

Help employers find you! Check out all the jobs and post your resume.

Back to news